CELEBRATION, Fla. (AP) — CELEBRATION, Fla. (AP) — Zevra Therapeutics, Inc. (ZVRA) on Thursday reported a loss of $15.2 million in its fourth quarter.
The Celebration, Florida-based company said it had a loss of 40 cents per share.
The results fell short of Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 20 cents per share.
The specialty pharmaceutical company posted revenue of $13.2 million in the period, which also fell short of Street forecasts. Three analysts surveyed by Zacks expected $13.4 million.
For the year, the company reported a loss of $46 million, or $1.30 per share. Revenue was reported as $27.5 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ZVRA at https://www.zacks.com/ap/ZVRA
Copyright © 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, written or redistributed.
